title: Stage I clear cell sarcoma of the kidney: is it the time for a less intensive adjuvant treatment?
abstract: Clear cell sarcoma of the kidney (CCSK) is a rare type of renal tumor, comprising 2% to 5% of all primary renal tumors in children. Despite the label of "unfavorable" tumor, with recent multimodality treatment schedules, including radiotherapy and multi-agent chemotherapy, disease free survival rates approaching 80% can be achieved. Younger age at tumor diagnosis and advanced-stage disease represent adverse prognostic factors. Of note, as a consequence of oncologic therapies a number of surviving patients have suffered from late sequelae on the musculoskeletal, gastrointestinal, hepatic, endocrine and cardiovascular function, or developed second tumors. Improved survival rates and a deeper knowledge of iatrogenic complications have promoted the awareness of a sequential reduction of treatment intensity, at least for low-stage CCSK, above all focusing on the abolition of flank radiation therapy (RT). It is fundamental to recognize that the rarity of this tumor calls for international cooperation trough controlled clinical trials, and without forgetting the key importance of a correct histological diagnosis and adequate surgical staging. The recent recognition of CCSK specific chromosomal translocation might help to guide targeted therapies complementary to conventional chemotherapy and radiotherapy.
authors.affiliation: 1 Pediatric Oncology Unit, Hematology and Pediatric Onco-Hematology Department, 2 Pediatric Radiotherapy Unit, Department of Radiology/Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy ; 3 Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", Departement of Pediatrics, University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
authors.forename: Filippo
authors.initials: F
authors.lastname: Spreafico
authors.affiliation: 1 Pediatric Oncology Unit, Hematology and Pediatric Onco-Hematology Department, 2 Pediatric Radiotherapy Unit, Department of Radiology/Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy ; 3 Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", Departement of Pediatrics, University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
authors.forename: Lorenza
authors.initials: L
authors.lastname: Gandola
authors.affiliation: 1 Pediatric Oncology Unit, Hematology and Pediatric Onco-Hematology Department, 2 Pediatric Radiotherapy Unit, Department of Radiology/Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy ; 3 Pediatric Oncology and Hematology Unit "Lalla Seràgnoli", Departement of Pediatrics, University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
authors.forename: Fraia
authors.initials: F
authors.lastname: Melchionda
keywords: Clear cell sarcoma of the kidney (CCSK); Wilms tumor; pediatric renal tumor
references.citation: Am J Surg Pathol. 2000 Jan;24(1):4-18
references.pmid: 10632483
references.citation: Cancer. 1989 Jul 15;64(2):349-60
references.pmid: 2544249
references.citation: Eur J Cancer. 2013 Nov;49(16):3497-506
references.pmid: 23880476
references.citation: Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):428-31
references.pmid: 22658515
references.citation: J Clin Oncol. 2004 Feb 1;22(3):468-73
references.pmid: 14752069
references.citation: Eur J Cancer. 2012 Sep;48(14):2219-26
references.pmid: 22579455
references.citation: Med Pediatr Oncol. 1997 May;28(5):355-7
references.pmid: 9121400
references.citation: Cancer. 1981 May 1;47(9):2302-11
references.pmid: 6164480
references.citation: Cancer. 1976 Aug;38(2):633-46
references.pmid: 184912
references.citation: Med Pediatr Oncol. 2002 Feb;38(2):79-82
references.pmid: 11813170
references.citation: J Clin Oncol. 1994 Oct;12(10):2132-7
references.pmid: 7931484
references.citation: J Clin Oncol. 1998 Jan;16(1):237-45
references.pmid: 9440748
references.citation: Br J Cancer. 1978 Sep;38(3):437-41
references.pmid: 708576
references.citation: J Pathol. 2012 May;227(1):72-80
references.pmid: 22294382